Phase II study of gemcitabine in non small cell lung cancer (NSCLC): B. Lund, H. Anderson, J. Walling, N. Thatcher, H.H.Hansen Dept. of Oncology, Rigshospitalet, Copenhagen, Denmark, and Wythenshawe Hospital, Manchester, England
- 31 December 1991
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 7, 121
- https://doi.org/10.1016/0169-5002(91)91801-h